Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.
Romei C, Casella F, Tacito A, Bottici V, Valerio L, Viola D, Cappagli V, Matrone A, Ciampi R, Piaggi P, Ugolini C, Torregrossa L, Basolo F, Materazzi G, Vitti P, Elisei R. Romei C, et al. Among authors: casella f. J Med Genet. 2016 Nov;53(11):729-734. doi: 10.1136/jmedgenet-2016-103833. Epub 2016 Jul 28. J Med Genet. 2016. PMID: 27468888
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
Ciampi R, Romei C, Pieruzzi L, Tacito A, Molinaro E, Agate L, Bottici V, Casella F, Ugolini C, Materazzi G, Basolo F, Elisei R. Ciampi R, et al. Among authors: casella f. J Endocrinol Invest. 2017 Jan;40(1):55-62. doi: 10.1007/s40618-016-0526-5. Epub 2016 Aug 17. J Endocrinol Invest. 2017. PMID: 27535135
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, Matrone A, Biagini A, Casella F, Ciampi R, Materazzi G, Miccoli P, Torregrossa L, Ugolini C, Basolo F, Vitti P, Elisei R. Romei C, et al. Among authors: casella f. Clin Endocrinol (Oxf). 2015 Jun;82(6):892-9. doi: 10.1111/cen.12686. Epub 2014 Dec 29. Clin Endocrinol (Oxf). 2015. PMID: 25440022
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
Elisei R, Lorusso L, Piaggi P, Torregrossa L, Pellegrini G, Molinaro E, Agate L, Bottici V, Pani F, Cacciato Insilla A, Casella F, Ciampi R, Tognetti I, Materazzi G, Basolo F, Romei C. Elisei R, et al. Among authors: casella f. Eur J Endocrinol. 2015 Sep;173(3):297-304. doi: 10.1530/EJE-15-0304. Epub 2015 Jun 1. Eur J Endocrinol. 2015. PMID: 26034076
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.
Provenzano L, Gwee YX, Conca V, Lonardi S, Bozzarelli S, Tamburini E, Passardi A, Zaniboni A, Tosi F, Aprile G, Nasca V, Boccaccino A, Ambrosini M, Vetere G, Carullo M, Guaglio M, Battaglia L, Zhao JJ, Chia DKA, Yong WP, Tan P, So J, Kim G, Shabbir A, Ong CJ, Casella F, Cremolini C, Bencivenga M, Sundar R, Pietrantonio F. Provenzano L, et al. Among authors: casella f. Ther Adv Med Oncol. 2024 Nov 4;16:17588359241289517. doi: 10.1177/17588359241289517. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39502404 Free PMC article.
Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study.
Magna A, Maggio E, Vidili G, Sciacqua A, Cogliati C, Di Giulio R, Bernardini S, Fallarino A, Palumbo IM, Pannunzio A, Bagnato C, Serra C, Boddi M, Falsetti L, Zaccone V, Ettorre E, Desideri G, Santoro L, Cantisani V, Pignatelli P, Santoliquido A, Violi F, Loffredo L; AURELIO Study Group. Magna A, et al. Thromb Res. 2024 Nov;243:109148. doi: 10.1016/j.thromres.2024.109148. Epub 2024 Sep 11. Thromb Res. 2024. PMID: 39326194 Free article.
Epidemiology and Clinical Insights of Catheter-Related Candidemia in Non-ICU Patients with Vascular Access Devices.
Scaglione G, Colaneri M, Offer M, Galli L, Borgonovo F, Genovese C, Fattore R, Schiavini M, Taino A, Calloni M, Casella F, Gidaro A, Fassio F, Breschi V, Leoni J, Cogliati C, Gori A, Foschi A. Scaglione G, et al. Among authors: casella f. Microorganisms. 2024 Aug 6;12(8):1597. doi: 10.3390/microorganisms12081597. Microorganisms. 2024. PMID: 39203438 Free PMC article.
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Robella M, Vaira M, Ansaloni L, Asero S, Bacchetti S, Borghi F, Casella F, Coccolini F, De Cian F, di Giorgio A, Framarini M, Gelmini R, Graziosi L, Kusamura S, Lippolis P, Lo Dico R, Macrì A, Marrelli D, Sammartino P, Sassaroli C, Scaringi S, Tonello M, Valle M, Sommariva A. Robella M, et al. Among authors: casella f. Eur J Surg Oncol. 2024 Sep;50(9):108486. doi: 10.1016/j.ejso.2024.108486. Epub 2024 Jun 13. Eur J Surg Oncol. 2024. PMID: 38971013
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape.
Morgagni P, Bencivenga M, Carneiro F, Cascinu S, Derks S, Di Bartolomeo M, Donohoe C, Eveno C, Gisbertz S, Grimminger P, Gockel I, Grabsch H, Kassab P, Langer R, Lonardi S, Maltoni M, Markar S, Moehler M, Marrelli D, Mazzei MA, Melisi D, Milandri C, Moenig PS, Mostert B, Mura G, Polkowski W, Reynolds J, Saragoni L, Van Berge Henegouwen MI, Van Hillegersberg R, Vieth M, Verlato G, Torroni L, Wijnhoven B, Tiberio GAM, Yang HK, Roviello F, de Manzoni G; Bertinoro Workshop Working Group. Morgagni P, et al. Gastric Cancer. 2024 Jul;27(4):672-674. doi: 10.1007/s10120-024-01520-7. Gastric Cancer. 2024. PMID: 38884884 Free PMC article. No abstract available.
153 results